 Connection
Matthew Greenhawt to Administration, Intranasal
This is a "connection" page, showing publications Matthew Greenhawt has written about Administration, Intranasal.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.515 |
|
|
|
-
Shaker MS, Oppenheimer J, Rider NL, Golden DBK, Anagnostou A, Greenhawt M. A health economic analysis of noninjectable epinephrine compared with intramuscular epinephrine. Ann Allergy Asthma Immunol. 2025 May; 134(5):587-593.e1.
Score: 0.233
-
Greenhawt M, Lieberman J, Blaiss M, Bernstein DI, Oppenheimer J, DuBuske L, Fleischer D, Dworaczyk DA. Pharmacokinetic and Pharmacodynamic Profile of Epinephrine Nasal Spray Versus Intramuscular Epinephrine Autoinjector in Healthy Adults. J Allergy Clin Immunol Pract. 2024 Dec; 12(12):3274-3282.e2.
Score: 0.231
-
Rank MA, Chu DK, Bognanni A, Oykhman P, Bernstein JA, Ellis AK, Golden DBK, Greenhawt M, Horner CC, Ledford DK, Lieberman J, Luong AU, Orlandi RR, Samant SA, Shaker MS, Soler ZM, Stevens WW, Stukus DR, Wang J, Peters AT. The Joint Task Force on Practice Parameters GRADE guidelines for the medical management of chronic rhinosinusitis with nasal polyposis. J Allergy Clin Immunol. 2023 02; 151(2):386-398.
Score: 0.051
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|